Improving dexamethasone drug loading and efficacy in treating rheumatoid arthritis via liposome: Focusing on inflammation and molecular mechanisms

Improving dexamethasone drug loading and efficacy in treating rheumatoid arthritis via liposome: Focusing on inflammation and molecular mechanisms

Abstract Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects approximately 0.46% of the global population. Conventional therapeutics for RA, including disease‐modifying antirheumatic drugs (DMARDs), nonsteroidal anti‐inflammatory drugs (NSAIDs), and corticosteroids, frequently res...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammad Yasin Zamanian, Hamidreza Zafari, Maria K. Osminina, Alla A. Skakodub, Raed Fanoukh Aboqader Al‐Aouadi, Maryam Golmohammadi, Nikta Nikbakht, Iman Fatemi
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Animal Models and Experimental Medicine
Subjects:
dexamethasone
inflammation
liposome
rheumatoid arthritis
TNF‐α
Online Access:https://doi.org/10.1002/ame2.12518
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/ame2.12518

Similar Items